N-(4-Cyanophenyl)guanidine

We are N-(4-Cyanophenyl)guanidine CAS:5637-42-3 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:N-(4-Cyanophenyl)guanidine
CAS.NO:5637-42-3
Synonyms:N-(4-Cyanophenyl)guanidine
1-(4-cyanophenyl)guanidine
4-Guanidinobenzonitrile
 
Physical and Chemical Properties:
mical & Physical Properties
Density 1.3±0.1 g/cm3
Boiling Point 316.6±44.0 °C at 760 mmHg
Melting Point 155-162°C
Molecular Formula C8H8N4
Molecular Weight 160.176
Flash Point 145.3±28.4 °C
Vapour Pressure 0.0±0.7 mmHg at 25°C
Index of Refraction 1.633
 
Specification:
Appearance:White crystal
Assay(HPLC):≥98.0%
Melting Point:205-215°C
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Etravirine(CAS:269055-15-4) and Rilpivirine(CAS:500287-72-9).

N-(4-Cyanophenyl)guanidine


Related News: Under the terms of this agreement, Inceptua will support Onconova through the pre-approval provision of intravenous rigosertib initially into a number of countries including: Australia, Denmark, Finland, France, Ireland, Italy, the Netherlands, Portugal, South Africa, Spain, and the UK.ciclobutanecarbaldehyde CAS:2987-17-9 Under the terms of this agreement, Inceptua will support Onconova through the pre-approval provision of intravenous rigosertib initially into a number of countries including: Australia, Denmark, Finland, France, Ireland, Italy, the Netherlands, Portugal, South Africa, Spain, and the UK.4-(1,2-Benzothiazol-3-yl)-1-[(3aR,7aR)-octahydro-2H-isoindol-2-yl ]piperazin-1-ium-1-sulfonate Under the terms of this agreement, Inceptua will support Onconova through the pre-approval provision of intravenous rigosertib initially into a number of countries including: Australia, Denmark, Finland, France, Ireland, Italy, the Netherlands, Portugal, South Africa, Spain, and the UK.10-bromobenzo [b] nafto [1,2-d] furano CAS:1256544-20-3 Under the terms of this agreement, Inceptua will support Onconova through the pre-approval provision of intravenous rigosertib initially into a number of countries including: Australia, Denmark, Finland, France, Ireland, Italy, the Netherlands, Portugal, South Africa, Spain, and the UK.Refers to the active pharmaceutical ingredients used in the manufacture of original research drugs (patent drugs or innovative drugs). It mainly meets the needs of international original research drug companies and emerging biopharmaceutical companies for innovative drugs at various stages of clinical research, registration approval and commercialization of drugs. Contains advanced intermediates used in the manufacture of this drug substance that need to be regulated by regulatory authorities.

Related Products
Product Name
Chroman-4-one View Details
methyl 2-(isocyanatosulfonylmethyl)benzoate View Details
(3R,4S)-3-Hydroxy-4-phenylazetidin-2-one View Details
Methyl 6-fluoro-1H-indole-4-carboxylate manufacturer O-5,6,7,8-Tetrahydro-2-naphtylthiochloroformate manufacturer Ethyl 4-(1-hydroxy-1-methylethyl)-2-propyl-imidazole-5-carboxylate manufacturer 3-(Trifluoromethoxy)bromobenzene manufacturer 1-Fluoro-10-chlorodecane manufacturer